In addition, qRT-PCR was performed to explore the expression differences between CRC and adjacent normal tissues, and the results suggested that CXCL9 and TRIB2 might be potential diagnostic or therapeutic targets of CRC. The gene discussed is TRIB2; the disease is colorectal carcinoma.